Call for expressions of interest (Португалия - Тендер #47873096)

2023102720240117European Institution/Agency or International OrganisationCall for expressions of interestServicesNot specifiedEuropean Institution/Agency or International OrganisationNot specifiedNot specifiedAG3M0I.1Name, addresses and contact point(s)European Union Drugs Agency (EUDA), National ID: PT, Praça Europa 1, Cais do Sodré, 1249-289 Lisbon, PORTUGAL (PT)Contact point(s)For the attention of: Vivianne Rodriguez, Procurement OfficerTelephone: +351 211210298Fax: +351 210193502E-mail: info.procurement@emcdda.europa.euInternet address(es)General address of the contracting authority (URL): LOE@emcdda.europa.euElectronic access to information (URL): https://www.emcdda.europa.eu/about/sc/call-loe-nps-2023_enElectronic submission of applications (URL): https://ec.europa.eu/eusurvey/runner/loeFurther information can be obtained from the above mentioned contact point(s)Specifications and additional documents can be obtained from the above mentioned contact point(s)Applications must be sent to the above mentioned contact point(s)

I.2)Type of the contracting authorityEuropean institution/agency or international organisation

I.3)Main activityOther: European Union Drugs Agency (EUDA)

I.4)Contract award on behalf of other contracting authoritiesThe contracting authority is purchasing on behalf of other contracting authorities: no.

II.1)Title attributed to the call for expressions of interest:Call for expressions of interest for inclusion on the List of Experts to be used by the EUDA Executive Director to extend the EUDA Scientific Committee for the purposes of the assessment of the risks posed by new psychoactive substances, in accordance with Article 31(6) of the EUDA Regulation.

II.2)Type of contract and location of works, place of delivery or of performanceServicesCategory No:27 Other servicesMain site or location of works, place of delivery or of performance:European Union Drugs Agency (EUDA).NUTS code PT17 Área Metropolitana de Lisboa

II.3)Description of the field or fields covered by the call for expressions of interest:This call is addressed to experts who wish to be considered for inclusion on the list of experts to be used by the Executive Director of the European Union Drugs Agency (EUDA) to extend the EUDA Scientific Committee for the purposes of the assessment of the risks posed by new psychoactive substances.The EUDA, based in Lisbon, Portugal, was established to (1):(a) provide the European Union and its Member States with factual, objective, reliable and comparable information, early warning and risk assessment at Union level concerning drugs, drug use, drug use disorders and addictions, prevention, treatment, care, risk and harm reduction, rehabilitation, social reintegration, recovery, drug markets and supply, including illicit production and trafficking, and other relevant drug related issues and their consequences;(b) and recommend appropriate and concrete evidence-based actions on how to address the challenges set out in point (a) in an efficient and timely manner.For additional information on the EUDA, please see: (https://www.emcdda.europa.eu/news/2023/6/new-legislation-grants-europe-stronger-powers-tackle-current-and-future-drug-problems_en).In order to ensure a balanced assessment of the risks posed by a new psychoactive substance, the EUDA Scientific Committee may be extended as deemed necessary by the EUDA Executive Director, acting on the advice of the Chairperson of the Scientific Committee, by including additional experts. These experts are designated by the Executive Director from a list of experts approved by the Management Board of the EUDA in view of their experience and expertise related to the areas assessed during a risk assessment.This call is addressed to experts who wish to be considered for inclusion on a list of experts to be used by the Executive Director to extend the Scientific Committee for the purposes of ensuring a balanced assessment of the risks posed by new psychoactive substances in accordance with Article 31(6) of the Regulation (EC) No 2023/1322 (1).The selected experts will be included, in a personal capacity, on a list to be approved by the EUDA Management Board for a 4-year period. The experts from the approved list shall be independent and shall act in the public interest. They shall neither seek nor take instructions from any government or from any other body. The EUDA Management Board may decide to extend the validity of the approved list of experts for further 4 years.Risk assessment meetings are held on an ad hoc basis in accordance with Article 10 of the EUDA Regulation at the EUDA premises in Lisbon. The vehicular working language of the risk assessment procedure and risk assessment meetings is English.Each expert designated by the Executive Director to extend the Scientific Committee for the purpose of a risk assessment will be entitled to receive an allowance for each day of attendance to the meeting held for this assessment. Furthermore, they will be entitled to the refunding of the travel, accommodation and subsistence expenses exposed for this attendance. The conditions and terms of the above-referred entitlements will be the ones applied for the appointed members of the Scientific Committee, in accordance with the rules in force at the EUDA for this purpose.Each expert designated by the Executive Director to extend the Scientific Committee for the purpose of a risk assessment shall sign a declaration of independence in relation to the performance of his/her duties in and for this body, and shall fill in and sign a written declaration of interest covering current and past interests up to 5 years before the date of the declaration. These declarations will be made available for public scrutiny on the EUDA website, with due respect to EU rules on protection of personal data.Pursuant to the rules applicable for the definition of the list of experts to be used to extend the EUDA Scientific Committee for the purposes of the assessment of the risks posed by new psychoactive substances, these experts must be nationals of a Member State of the European Union (EU) or of a country which has concluded an agreement with the latter for the purpose of the participation in the work of the EUDA. This requirement is a condition of eligibility for the selection and the inclusion on the above referred list. If this condition is not met, this will determine the exclusion of the concerned person from the selection process and/or from the approved list of experts, as from the moment when this condition is not met.Further information on this call, including procedures, arrangements and the requirements for eligibility and selection, are available from the EUDA website: (https://www.emcdda.europa.eu/about/sc/call-loe-nps-2023_en).Expressions of interest have to be submitted online via EUSurvey: (https://ec.europa.eu/eusurvey/runner/loe).If you have any question about this call, please email to: LOE@emcdda.europa.euClosing dateThe closing date for submission of expressions of interest is 17 January 2024 at 23:59, Lisbon time (date and hour of submission to EUSurvey). The EUDA reserves the right to disregard any expressions of interest submitted after that date.(1) OJ L 166, 30.6.2023, p. 6–47. https://eur-lex.europa.eu/eli/reg/2023/1322/oj

II.4)Information about lotsThis call for expressions of interest is divided into lots: no.Applications may be submitted for: one lot only.

II.5)Information about subcontractingThe subcontracting is accepted: no.

II.6)Common procurement vocabulary (CPV)71317210 Health and safety consultancy services

III.1)Legal form to be taken by the grouping of suppliers, contractors or service providers to whom a contract might be awarded:Not applicable.

III.2)Economic and financial standing:Not applicable.

III.3)Technical competence:Not applicable.

III.4)Professional competence:Not applicable.

IV.1)Type of procedureRestricted

IV.2)Grounds for exclusionApplicants shall be excluded from participating in a contract if:(a) they are bankrupt, being wound up or have suspended business activities, their affairs are being administered by the court, they have entered into an arrangement with creditors or similar measures or are the subject of any proceedings of that nature, or are in any analogous situation arising from a similar procedure provided for in national legislation or regulations;(b) they have been convicted of an offence concerning their professional conduct by a judgment which is not open to appeal;(c) they have been guilty of grave professional misconduct;(d) they have not fulfilled obligations relating to the payment of social security contributions or taxes;(e) they are guilty of serious misrepresentation in supplying the information required by the authorizing department.

IV.3)Selection criteria:Procedure for the selection and inclusion on the List of Experts to be used by the EUDA Executive Director to extend the EUDA Scientific Committee for the purposes of the assessment of the risks posed by new psychoactive substances are available at: (https://www.emcdda.europa.eu/about/sc/call-loe-nps-2023_en).

IV.4)Administrative informationIV.4.1) File reference number:LOE23IV.4.2) Period of validity of the list resulting from this call for expressions of interests:Expiry date of the list resulting from the call for expressions of interest:Date: 17.1.2024IV.4.3) Time-limit for the submission of applications:17.1.2024IV.4.4) Language(s) in which applications may be submitted:Official EU language(s):English

Vl.1)Presentation and submission of applications:Not applicable.

Vl.2)Additional information:Not applicable.

Vl.3)Date of dispatch of this notice:27.10.2023.

Источник закупки

Перейти

Импорт - Экспорт по стране Португалия